Glipizide
Glipizide is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Glipizide; Generic name: GLIPIZIDE; Drug class: Sulfonylurea [EPC].
| Brand name | Glipizide |
|---|---|
| Generic name | GLIPIZIDE |
| Drug class | Sulfonylurea [EPC] |
| Manufacturer | Preferred Pharmaceuticals Inc.. |
| Used for | INDICATIONS AND USAGE Glipizide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. |
| Dosage | DOSAGE AND ADMINISTRATION There is no fixed dosage regimen for the management of diabetes mellitus with glipizide or any other hypoglycemic agent. In addition to the usual monitoring of urinary glucose, the patient’s blood glucose must also be monitored periodically to determine the minimum effective dose for the patient; to detect primary failure, i.e., inadequate lowering of blood glucose at the maximum recommended dose of medication; and to detect secondary failure, i.e., loss of an adequate |
| Warnings | WARNINGS SPECIAL WARNING ON INCREASED RISK OF CARDIOVASCULAR MORTALITY: The administration of oral hypoglycemic drugs has been reported to be associated with increased cardiovascular mortality as compared to treatment with diet alone or diet plus insulin. This warning is based on the study conducted by the University Group Diabetes Program (UGDP), a long-term prospective clinical trial designed to evaluate the effectiveness of glucose-lowering drugs in preventing or delaying vascular complicatio |
| Active ingredient(s) | GLIPIZIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=02857195-33e9-4c1f-9e5f-7cc62f283649 |